Background: The COVID-19 outbreak in Wuhan started in December 2019 and was under control by the end of March 2020 with a total of 50,006 confirmed cases by the implementation of a series of nonpharmaceutical interventions (NPIs) including unprecedented lockdown of the city. This study analyzes the complete outbreak data from Wuhan, assesses the impact of these public health interventions, and estimates asymptomatic and undetected cases in the outbreak.
Methods: By taking different stages of the outbreak into account, we developed a time-dependent compartmental model to describe the dynamics of disease transmission and case detection and reporting. Model coefficients were parameterized by using the reported cases and following key events and escalated control strategies. Then the model was used to calibrate the complete outbreak data by using the Monte Carlo Markov Chain (MCMC) method. Finally we used the model to estimate asymptomatic and undetected cases and approximate the overall antibody prevalence level.
Results: We found that the transmission rate between Jan 24 and Feb 1 was twice as large as that before the lockdown on Jan 23 and 67.6% (95% CI [0.584; 0.759]) of detectable infections occurred during this period.. Based on the reported estimates that around 20% of infections were asymptomatic and their transmission ability was about 70% of symptomatic ones, we estimated that there were about 14,448 undetected cases (95% CI [12,364; 23,254]), which yields an estimate of a total of 64,454 infected cases (95% CI [62,370; 73,260]), and the overall antibody prevalence level in the population of Wuhan was 0.745% (95% CI [0.693%, 0.814%]) by March 31, 2020.
Conclusions: We conclude that the control of the COVID-19 outbreak in Wuhan was achieved via the enforcement of a combination of multiple NPIs: the lockdown on Jan 23, the stay-at-home order on Feb 2, the massive isolation of all symptomatic individuals via newly constructed special shelter hospitals on Feb 6, and the large scale screening process on Feb 18. Our results indicate that the population in Wuhan is far away from establishing herd immunity and provide insights for other affected countries and regions in designing control strategies and adjusting reopen plans.